|
ELF2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.43682893045161E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96369998040069E-09 |
| Normal-vs-Stage2 |
7.89520000044064E-07 |
| Normal-vs-Stage3 |
1.69629998936216E-09 |
| Normal-vs-Stage4 |
2.1744994693762E-10 |
| Stage1-vs-Stage2 |
4.646200E-01 |
| Stage1-vs-Stage3 |
1.693050E-01 |
| Stage1-vs-Stage4 |
1.158250E-02 |
| Stage2-vs-Stage3 |
7.938000E-01 |
| Stage2-vs-Stage4 |
2.664800E-01 |
| Stage3-vs-Stage4 |
2.962600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.18498569132453E-12 |
| Normal-vs-AfricanAmerican |
1.380010E-03 |
| Normal-vs-Asian |
7.90449999999998E-05 |
| Caucasian-vs-AfricanAmerican |
3.757200E-01 |
| Caucasian-vs-Asian |
1.885000E-01 |
| AfricanAmerican-vs-Asian |
9.368400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.30869999784389E-08 |
| Normal-vs-Female |
9.42468325604295E-12 |
| Male-vs-Female |
5.199400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.17640000466091E-08 |
| Normal-vs-Age(41-60Yrs) |
5.98409988228354E-10 |
| Normal-vs-Age(61-80Yrs) |
6.3674954198234E-11 |
| Normal-vs-Age(81-100Yrs) |
5.578900E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.784800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.262300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.495600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.254200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.647200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.394000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.961330E-03 |
| Classical-VS-Follicular |
1.157630E-01 |
| Classical-VS-Other |
9.572200E-01 |
| Classical-VS-Normal |
1.9415999918948E-09 |
| Tall-VS-Follicular |
1.546030E-01 |
| Tall-VS-Other |
1.439590E-01 |
| Tall-VS-Normal |
1.07989994724278E-09 |
| Follicular-VS-Other |
5.893000E-01 |
| Follicular-VS-Normal |
4.91249999567955E-08 |
| Other-VS-Normal |
4.654400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.31000005182602E-10 |
| Normal-vs-N1 |
3.31450000001787E-07 |
| N0-vs-N1 |
9.964200E-01 |
|
|
